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Abstract 
Renal tissue hypoperfusion and hypoxia are key elements in the pathophysiology of 
acute kidney injury and its progression to chronic kidney disease. Yet, in vivo assessment of 
renal haemodynamics and tissue oxygenation remains a challenge. Many of the established 
approaches are invasive, hence not applicable in humans. Blood oxygenation level dependent 
(BOLD) magnetic resonance imaging (MRI) offers an alternative. BOLD-MRI is non-
invasive and indicative of renal tissue oxygenation. Nonetheless recent (pre-)clinical studies 
revived the question as to how bold renal BOLD-MRI really is. This review aims to deliver 
some answers. It is designed to inspire the renal physiology, nephrology, and imaging 
communities to foster explorations into the assessment of renal oxygenation and 
haemodynamics by exploiting the powers of MRI. For this purpose the specifics of renal 
oxygenation and perfusion are outlined. The fundamentals of BOLD-MRI are summarized. 
The link between tissue oxygenation and the oxygenation sensitive MR biomarker T2* is 
outlined. The merits and limitations of renal BOLD-MRI in animal and human studies are 
surveyed together with their clinical implications. Explorations into detailing the relation 
between renal T2* and renal tissue partial pressure of oxygen (pO2) are discussed with a focus 
on factors confounding the T2* versus tissue pO2 relation. Multi-modality in vivo approaches 
suitable for detailing the role of the confounding factors that govern T2* are considered. A 
schematic approach describing the link between renal perfusion, oxygenation, tissue 
compartments and renal T2* is proposed. Future directions of MRI assessment of renal 
oxygenation and perfusion are explored. 
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Introduction 
Kidney diseases are a global health burden with steadily increasing incidence (Eckardt 
et al., 2013, Lameire et al., 2013, Leung et al., 2013). Two million per year is the estimated 
worldwide death toll of acute kidney injury (AKI) (Thakar et al., 2009, Thakar, 2013, Ali et 
al., 2007). Renal tissue hypoperfusion and hypoxia are considered to be key elements in the 
pathophysiology of AKI and the progression from acute kidney injury to chronic kidney 
diseases (CKD) (Persson, 2013a, Singh et al., 2013, Evans et al., 2008b, Evans et al., 2011a, 
Evans et al., 2013, Chawla and Kimmel, 2012, Seeliger et al., 2012, Legrand et al., 2008). 
Disturbance of the balance between renal oxygen supply and demand is also suggested to play 
a major role in the pathophysiology of diabetic nephropathy (Friederich-Persson et al., 2013, 
Hansell et al., 2013). Admittedly, it is too early to make ultimate statements on the role of 
renal hypoperfusion and hypoxia in these renal disorders since in vivo assessment of renal 
haemodynamics and oxygenation constitutes a challenge. All modalities available in current 
experimental and translational research practice have inherent limitations and methodological 
shortcomings (Evans et al., 2008b, Prasad, 2006b, Evans et al., 2007, Pohlmann et al., 2013a). 
Many of the established approaches are invasive, hence applicable in animal studies but not in 
humans. On the clinical side, prevention and therapy of AKI and CKD largely rely on 
empirical knowledge. With an increasing incidence of AKI in all acute care hospitalizations, 
risk assessment strategies and therapeutic options are limited (Thakar et al., 2009, Thakar, 
2013, Hoste and Schurgers, 2008, Ali et al., 2007, Chertow et al., 2005). Translational 
approaches - although urgently warranted - are still scarce (Zarjou et al., 2012, Evans et al., 
2013). The magnitude of unsolved problems and clinical needs motivated a recent quest for 
putting extra weight behind explorations into haemodynamic influences on kidney 
oxygenation to enhance the understanding of renal diseases that are induced or promoted by 
renal tissue hypoperfusion and hypoxia (Evans et al., 2013). The impact of changes in renal 
haemodynamics on tissue oxygenation, by virtue of the complexity of renal 
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(patho)physiology, cannot necessarily be predicted intuitively. It requires a comprehensive 
approach using multi-faceted measuring modalities including non-invasive imaging such as 
ultrasound, computer tomography and magnetic resonance imaging (Brabrand et al., 2014, 
Damkjaer et al., 2012, Pohlmann et al., 2013a) that may be supported by insights from 
simulations modeling renal tissue (Evans et al., 2013, Zhang et al., 2014).  
Magnetic resonance imaging (MRI) offers a non-invasive technique to obtain insight 
into renal perfusion and oxygenation under (patho)physiological conditions (Zhang et al., 
2013). MRI affords full kidney coverage, soft tissue contrast that helps to differentiate the 
renal layers, seconds to minutes temporal resolution, support of longitudinal studies and high 
anatomic detail (Prasad and Epstein, 1999, Prasad et al., 2001, Prasad, 2006b, Li et al., 2008, 
Haque et al., 2011, Michaely et al., 2012, Arakelyan et al., 2013b, Pohlmann et al., 2013a, 
Pohlmann et al., 2013b, Hueper et al., 2013). Blood oxygenation level dependent (BOLD) 
MRI is thought - if not touted - to provide a surrogate of renal tissue oxygenation (Prasad and 
Epstein, 1999, Prasad et al., 2001, Prasad, 2006b, Li et al., 2008, Haque et al., 2011, Peng et 
al., 2013, Morrell et al., 2013, Menzies et al., 2013, Pruijm et al., 2013a, Pruijm et al., 2013b, 
Pruijm et al., 2013c, Liss et al., 2013, Gloviczki et al., 2011, Rognant et al., 2012, Park et al., 
2012, Donati et al., 2012, Ebrahimi et al., 2012, Chrysochou et al., 2012, Rognant et al., 2011, 
Warner et al., 2011, Gloviczki et al., 2009, Rossi et al., 2013). Renal BOLD-MRI 
methodology has matured and a broad range of preclinical and clinical applications have been 
reported. The eye-opening quality of the anatomical and functional images of the kidney 
created excitement among the diagnostic imaging community and is the driving force for 
broader clinical studies. The clinical implications feed into a broad spectrum of physiology, 
nephrology, radiology and other related fields of basic science and clinical research. The ever 
growing number of pioneering reports eloquently referring to renal BOLD-MRI is an inherent 
testament to the value of non-invasive MRI to renal (patho)physiology. This progress creates 
the temptation to sing the praises of renal BOLD-MRI. Yet recent findings and considerations 
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derived from renal BOLD-MRI in preclinical and human studies revitalized and nurtured the 
reflective and intense debate on “how bold is BOLD-MRI of the kidney?” (Mason, 2006, 
Evans et al., 2007, Michaely et al., 2012, Neugarten, 2012, Pohlmann et al., 2013a, Arakelyan 
et al., 2013, Pohlmann et al., 2014a). 
Realizing the progress, opportunities, challenges and caveats of renal BOLD-MRI this 
review is not a literature survey but an attempt to inspire the renal physiology, nephrology, 
biomedical and diagnostic imaging communities to foster explorations into the remaining 
unresolved questions and technical obstacles behind non-invasive assessment of renal 
oxygenation and haemodynamics. To meet this goal, this review first outlines the specifics of 
renal oxygenation and perfusion. Then the basic physical and biophysical principles of 
BOLD-MRI are described. This includes the link between tissue oxygenation and the MR 
based biomarker T2*, which provides a surrogate for blood oxygenation. Early and frontier 
applications of renal BOLD-MRI in small animal and human studies are explored together 
with their clinical implications. Recent explorations into detailing the relation between renal 
T2* and renal tissue partial pressure of oxygen (pO2) are discussed. Experimental results that 
underscore the factors confounding the T2*/tissue pO2 relation are surveyed. Multi-modality 
in vivo approaches for probing renal perfusion and oxygenation including parametric MRI, 
quantitative physiological measurements and optical imaging techniques are considered. An 
empirical approach that describes the link between renal perfusion, renal oxygenation, tissue 
compartments and renal T2* is proposed. A concluding section ventures a glance beyond the 
horizon and explores future directions of MRI based assessment of renal oxygenation and 
perfusion. 
All the animal experiments performed by the authors and shown in the figures were 
carried out in accordance with published guidelines (Persson, 2013b). 
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Unique aspects of renal haemodynamics and oxygenation 
  Renal oxygenation constitutes a delicate balance between oxygen delivery, as 
determined by renal blood flow and arterial O2 content, and O2 consumption, for which 
energy-dependent tubular reabsorption is the major determinant. Increased renal blood flow 
(RBF) is, in general, accompanied by increased glomerular filtration rate (GFR), and therefore 
necessitates increased tubular reabsorption (Blantz and Deng, 2007, O'Connor, 2006, Rosen et 
al., 1992, Evans et al., 2008b, Evans et al., 2013). As compared to most non-renal tissue, 
whole-kidney blood flow is high and whole-kidney arterio-venous difference in O2 content is 
small. Yet renal tissue perfusion and oxygenation is highly heterogeneous. Virtually all of the 
blood flowing into the kidney perfuses the cortex. The medulla is perfused by a small fraction 
(about 10% of total RBF) of blood that had traversed the cortex. Even intra-layer perfusion is 
quite heterogeneous. In accordance, tissue pO2 is low in the medulla and also varies within the 
respective layer (Edwards et al., 2000, O'Connor et al., 2006b, Evans et al., 2008a, Lubbers 
and Baumgartl, 1997, Evans et al., 2013). Three additional mechanisms substantially 
contribute to low renal tissue pO2. (i) The particular architecture of the intra-renal vasculature 
enables shunt diffusion of O2 from arteries to veins in the cortex as well as from descending to 
ascending vasa recta in the medulla. (ii) The vascular architecture also promotes differential 
distribution of erythrocytes and plasma at certain vessel branches (plasma skimming), which 
results in different haematocrit and O2 content of blood perfusing the daughter vessels. (iii) 
The Fåhræus-Lindqvist effect lowers the haematocrit in the long and narrow vasa recta 
supplying the medulla, which lowers the O2 content of blood perfusing the medulla. (Evans et 
al., 2008a, O'Connor et al., 2006a, Leong et al., 2007, Gardiner et al., 2012, Edwards et al., 
2000, Jonsson et al., 1992, Evans et al., 2013). Based upon studies on animal models of x-ray 
contrast-induced AKI, ischaemia/reperfusion injury, endotoxemic models of sepsis-induced 
AKI, and of diabetic nephropathy, intra-renal hypoxia is generally deemed a key 
pathophysiologic event in these disorders (Hoff et al., 2011, Seeliger et al., 2012, Heyman et 
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al., 2012, Brezis and Rosen, 1995, Evans et al., 2013, Legrand et al., 2008, Bellomo et al., 
2012, Singh et al., 2013, Friederich-Persson et al., 2013, Hansell et al., 2013, Abdelkader et 
al., 2014).  
The kidney is equipped with efficient mechanisms of autoregulation, i.e., the ability to 
maintain RBF and GFR relatively constant in the face of moderate changes in renal perfusion 
pressure (RPP) (Just, 2007, Seeliger et al., 2009). It has been suggested that autoregulatory 
mechanisms also serve the purpose of balancing O2 delivery with O2 demand that arises from 
tubular reabsorption. It is conceivable that in the setting of renal disorders autoregulatory 
mechanisms create a vicious circle in which low perfusion results in tissue hypoxia that in 
turn further reduces perfusion. (Blantz and Weir, 2004, O'Connor, 2006, Osswald et al., 1996, 
Seeliger et al., 2009, Evans et al., 2013). The differential perfusion and oxygenation of renal 
tissue is subject to changes induced by a variety of (patho)physiological factors. Alterations 
and redistributions of perfusion and/or of pO2 were reported from animal models emulating 
various forms of kidney disorders (Seeliger et al., 2007, Olof et al., 1991, Warner et al., 2009, 
Evans et al., 2011b, Evans et al., 2013, Pohlmann et al., 2013b, Hultstrom, 2013, Ahmeda et 
al., 2013, Liu et al., 2013). 
 
Blood oxygenation sensitive MRI 
BOLD-MRI is susceptible to bulk microscopic magnetic field perturbations around 
blood vessels which are induced by paramagnetic deoxygenated haemoglobin (Hb) (Ogawa et 
al., 1990, Ogawa, 2012). These microscopic magnetic field inhomogeneities affect the 
effective transversal MR relaxation time T2* (Zhao et al., 2007, Ogawa et al., 1990). T2* 
describes the loss of coherence and decay of the MR signal. T2* is governed by 
1/T2*=1/T2+1/T2', with T2 being the transverse relaxation time and T2' embodying 
susceptibility related contributions (Brown et al., 2014). T2* weighted MRI is sensitive to 
changes in the amount of deoxygenated Hb (deoxy Hb) per tissue volume element (voxel). 
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T2* decreases and a signal attenuation in T2*-weighted MR images occurs if the volume 
fraction of deoxy Hb increases. Although T2* is widely assumed to provide a surrogate of 
renal tissue oxygenation, variations in T2* may only reflect changes in blood oxygenation 
(Notohamiprodjo et al., 2010). This distinction is of relevance since renal blood oxygenation 
and renal tissue oxygenation can vary independently due to arterio-venous O2-shunting and 
plasma skimming (Evans et al., 2008b, Evans et al., 2007). Changes in [vessel volume]/[tissue 
volume] induced by active vasomotion or passive circular vessel distension/compression also 
alter the amount of deoxy Hb per tissue volume and hence T2* (Evans et al., 2008b).  
T2* sensitization is given by the echo time (TE). TE is defined by the time between 
MR signal excitation and MR signal readout (Bernstein et al., 2004). TE governs the loss of 
phase coherence of the MR signal due to spin dephasing (Bernstein et al., 2004). T2* 
sensitized MRI is most sensitive to blood oxygenation changes when TE is equal to T2*. 
Blood oxygenation induced T2* changes exhibit a linear relationship with the magnetic field 
strength (Turner et al., 1993, van der Zwaag et al., 2009, Donahue et al., 2011, Meloni et al., 
2013). The most widely used techniques for T2* sensitized renal MRI are echo-planar 
imaging (EPI) and gradient echo imaging (Brown et al., 2014, Bernstein et al., 2004). EPI 
offers excellent temporal resolution and reasonable spatial resolution. Notwithstanding this 
capability, EPI is prone to magnetic susceptibility artifacts. These artifacts present themselves 
as signal loss and image distortion. This effect is severe at high magnetic field strengths, since 
T2* is shortened versus low magnetic fields, and is particularly pronounced in regions with 
poor main magnetic field homogeneity. This constitutes a challenge for T2* sensitized MRI of 
renal areas adjacent to the intestine or abdominal fat. This challenge shifted the preference to 
gradient echo imaging. Gradient echo imaging affords an in-plane spatial resolution as good 
as 50 μm (Xie et al., 2012) in ex vivo MR microscopy (Figure 1a) of freshly excised kidneys 
(Figure 1b) and tissue contrast (Figure 1c) superior to x-ray (Figure 1d). In vivo gradient echo 
imaging of the kidney affords high anatomical detail using an in-plane spatial resolution as 
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good as about 220 m (Figure 1e). The heavy T2*-weighting required to make gradient echo 
images sensitive to changes in the blood oxygenation level necessitates a long TE. TE governs 
the T2* contrast between renal layers, i.e., cortex, outer medulla and inner medulla (Figure 
1f). Parametric mapping provides quantitative data of the relaxation time T2*. It is 
accomplished by acquiring a set of images each encoded with a different T2* weighting. This 
is achieved by altering TE values. Parametric mapping provides a means for monitoring renal 
T2* rather than tracking signal intensity changes in individual T2* weighted images of the 
kidney. Renal T2* mapping is primarily conducted with multi-echo gradient echo techniques, 
which acquire a train of gradient refocused echoes after the initial excitation, with each echo 
being independently T2* weighted. 
 
Opportunities of T2* sensitized MRI for probing renal oxygenation and 
perfusion 
The assumption that T2* provides a surrogate of renal tissue oxygenation is based 
upon the T2* dependence on O2 saturation of Hb (StO2) and motivated by the link between 
StO2, blood pO2, and tissue pO2. T2* or its reciprocal value (R2*=1/T2*) have been employed 
in numerous (pre)clinical studies as an MR based marker and surrogate of intra-renal 
oxygenation. T2*-mapping has been deemed ideally suited for probing intra-renal oxygenation 
(Prasad, 2006a). Renal T2* has even been suggested to exhibit a strong correlation with renal 
tissue pO2 (Pedersen et al., 2005). Accordingly, T2* sensitized MRI was employed in a broad 
spectrum of experimental research applications. Animal studies utilized T2*-based monitoring 
of renal oxygenation (i) during focal renal ischaemia (Vexler et al., 1993), renal 
ischaemia/reperfusion (Figure 2) (Oostendorp et al., 2011, Pohlmann et al., 2013b), and 
chronic renal artery stenosis (Rognant et al., 2011), (ii) following administration of x-ray 
contrast media (Arakelyan et al., 2013, Li et al., 2014, Zhang et al., 2012b, Haneder et al., 
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2012) (Figure 2), (iii) during reversible interventions including hypoxia (Figure 2), hyperoxia 
(Figure 2), and short-lasting aortic occlusion (Arakelyan et al., 2013), (iv) during acute 
unilateral ureteral obstruction (Pedersen et al., 2005), (v) following administration of diuretics 
(Kusakabe et al., 2010), (vi) during water loading (Ji et al., 2010) and (vii) in early stages of 
experimental diabetes (dos Santos et al., 2007).  
Numerous human studies confirmed the potential for clinical application of renal 
BOLD-MRI. BOLD-MRI has been reported to be efficient for assessment of human renal 
tissue oxygenation and its alterations induced by various interventions such as breathing of 
carbogen (95% O2, 5% CO2) or pure oxygen (Boss et al., 2009), administration of 
indomethacin or an x-ray contrast medium (Hofmann et al., 2006), infusion of diuretics 
(Gloviczki et al., 2010, Zhang et al., 2014, Hall et al., 2014), and acute unilateral ureteral 
obstruction by kidney stones (Thoeny et al., 2008). In patients with atherosclerotic renal 
artery stenosis pre and post stent revascularisation and in a control group of patients with 
essential hypertension BOLD-MRI showed a good relationship with renal perfusion (Saad et 
al., 2013). BOLD-MRI may also be used to assess the functional status of transplanted 
kidneys (Sadowski et al., 2005, Thoeny et al., 2006). All these explorations underscore the 
growing scope of T2* sensitized renal MRI and its value for the noninvasive assessment of 
renal oxygenation and perfusion.  
 
From qualitative to quantitative interpretation of renal BOLD-MRI 
Notwithstanding its potential to qualitatively probe renal oxygenation, the validity of 
the argument about the T2*/pO2 relation and efficacy of BOLD-MRI for quantitative and 
spatiotemporal characterization of renal tissue perfusion and oxygenation under various 
functional conditions requires further research. While it is a widely accepted notion that renal 
BOLD-MRI is qualitatively related to tissue pO2 the link between T2* and renal tissue pO2 is 
also recognized to be susceptible to the oxyHb dissociation curve, the haematocrit, and the 
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vascular volume fraction (Ogawa, 2012, Griffeth and Buxton, 2011, Evans et al., 2008b, 
Evans et al., 2007, Evans et al., 2008a). This added complexity creates a challenge for 
interpreting BOLD weighted MRI and parametric T2* mapping data (Michaely et al., 2012, 
Fine and Dharmakumar, 2012, Inoue et al., 2012, Evans et al., 2007).  
With this in mind it is not as much of a surprise – as it might appear at first glance – 
that an unambiguous physiological interpretation of renal T2* requires a calibration with gold 
standard quantitative physiological measurements including renal tissue pO2. This has largely 
remained elusive due to constraints dictated by MR compatibility and MR safety requirements 
and by practical obstacles and technical challenges associated with probe implementation 
within an MR system. A very limited number of studies attempted to investigate the link 
between established invasive methods and T2*-weighted MRI (Juillard et al., 2004, dos 
Santos et al., 2007, Li et al., 2009). These studies primarily relied on a comparison of MRI 
with invasive physiological measurements using independent cohorts of animals (dos Santos 
et al., 2007, Li et al., 2009). Alternatively, T2* and tissue pO2 were monitored sequentially in 
the same animal with the limitation that data acquisition was applied at different times 
(Warner et al., 2011). The literature shows a singular study which reports simultaneous 
monitoring of renal R2* and tissue pO2 (Pedersen et al., 2005). For this purpose the fraction of 
inspired oxygen (FiO2 range: 5-70%) was modulated in pigs. The authors reported R2* 
changes to be linearly related with tissue pO2 changes. Arguably, this conclusion appears 
somewhat premature, since T2* was recorded in the contralateral kidney while the pO2 probe 
was positioned in the ipsilateral kidney (Pedersen et al., 2005).  
Realizing the challenges and opportunities of tracking invasive physiological 
parameters and MR parameters simultaneously for the same kidney, an integrated multi-
modality approach designated as MR-PHYSIOL was recently employed (Pohlmann et al., 
2013a, Pohlmann et al., 2014a). MR-PHYSIOL combines established invasive measurements 
including arterial pressure, total renal blood flow, local tissue perfusion and tissue pO2 with 
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T2* mapping, T2 mapping, and kidney size measurements deduced from anatomical or 
functional MR images (Pohlmann et al., 2013a, Pohlmann et al., 2014a). MR-PHYSIOL has 
been applied for detailing the relation between renal T2* and renal oxygenation by use of a 
series of reversible interventions including a hypoxia/recovery maneuver in rats (Pohlmann et 
al., 2014a). Setting FiO2 to 8% induced arterial hypoxaemia. With arterial hypoxaemia tissue 
pO2 declined gradually, most prominently in the medulla: within 7 minutes medullary tissue 
pO2 had decreased by 96% and reached a steady state. T2* changes paralleled the changes in 
pO2, with T2* being reduced by 59% in the outer medulla and 37% in the inner medulla. 
Accordingly, hypoxia and recovery revealed a close medullary tissue pO2/T2* correlation as 
illustrated in Figure 3. This finding indicates that relative changes in T2* qualitatively reflect 
changes in medullary tissue pO2 induced by hypoxia which accords with the notion of the link 
between T2*, StO2, blood pO2, and tissue pO2.  
 
Challenges with quantitative interpretation of renal BOLD-MRI  
Notwithstanding the convincing results on the close medullary tissue pO2/T2* 
correlation during the hypoxic challenge, the notion that tissue pO2 and T2* are closely 
correlated per se for all renal layers and in various (patho)physiological scenarios might be 
premature. Haematocrit, oxyHb dissociation curve, and vascular volume fraction are well-
known confounders of the T2* to tissue pO2 relation and call for a careful scrutiny of this 
relation for all renal layers under various (patho)physiological scenarios and the necessity for 
calibration of T2* sensitized MRI for probing renal oxygenation and perfusion.  
 
Absolute regional renal T2* versus tissue pO2 levels under physiological conditions 
Perhaps stating the obvious, absolute renal T2* does not reflect tissue pO2. Absolute 
values of renal T2* in healthy rodents have been consistently found to be higher in the inner 
medulla versus the outer medulla and cortex as demonstrated in Figure 4b (Ries et al., 2003, 
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Rognant et al., 2011, dos Santos et al., 2007, Pohlmann et al., 2013b, Arakelyan et al., 2013, 
Pohlmann et al., 2014a). These findings do not match tissue pO2 levels measured by invasive 
methods, which provided the lowest average pO2 for the inner medulla (Lubbers and 
Baumgartl, 1997). One reason behind what seems to be a discrepancy at first glance is that 
T2* does not relate to the deoxyHb/oxyHb ratio, but to the absolute amount of deoxyHb per 
tissue volume. This observation indicates that T2* is sensitive to blood oxygenation but is also 
influenced by the blood vessel volume fraction and the local haematocrit. Vascular volume 
fraction and haematocrit are lowest in the inner medulla (Edwards et al., 2000). Also, water 
content in the inner medulla is higher than in the outer medulla and in the cortex (Hueper et 
al., 2013, Pohlmann et al., 2013b) as indicated by the high medullary signal in T2 weighted 
images (Figure 4c) and by the higher apparent water diffusion coefficient (ADC) in the inner 
medulla versus outer medulla as shown in Figure 4d.  
To generalize, the dependency of absolute renal T2* on the vascular volume fraction 
and haematocrit does not only preclude extrapolation of T2* obtained for one renal layer to 
another, but also from one species to another. 
 
T2* and tissue pO2 response to test interventions  
  Utilising MR-PHYSIOL while exposing rats to brief interventions of 
hyperoxia/recovery, aortic occlusion/recovery and hypoxia/recovery revealed major 
differences in T2*/pO2 correlations between the interventions (Pohlmann et al., 2014a).  
  Hyperoxia/recovery showed poor correlations for tissue pO2 changes versus T2* 
changes. This finding is plausible since almost all of the available Hb in arterial blood is 
already O2 saturated under normoxic conditions. Setting FiO2 to 100% barely lifts StO2 in 
arterial blood. However, this manoeuvre induces a substantial increase in pO2 of arterial 
blood. This enhances the driving force for O2 diffusion from vessels to tissue as well as from 
arteries to veins. As a consequence, the increase in renal tissue pO2 is substantial while that of 
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T2* – attributable to increased venous StO2 – is small.  
  For the aortic occlusion/recovery intervention a closer correlation between the relative 
changes of tissue pO2 and T2* was reported as compared to hyperoxia/recovery (Pohlmann et 
al., 2014a). Still, aortic occlusion caused a rather modest decrease of 11% in cortical T2* 
while cortical tissue pO2 revealed an 88% reduction as illustrated in Figure 5. In comparison, 
when using a spatially-resolved near-infrared spectroscopy (NIRS) setup (Grosenick et al., 
2013) – which enables quantitative estimation of Hb concentration per tissue volume element 
and of StO2 in the renal cortex – a decrease in StO2 by approximately 40% was found (Figure 
5) during aortic occlusion. Interestingly, NIRS detected a 30% decrease in the Hb 
concentration per cortical tissue volume within a few seconds after cessation of the arterial 
blood flow (Figure 5). MRI measurements revealed a 4% reduction in kidney size during 
aortic occlusion as shown in Figure 5.  
  These multi-modality data deduced from MR, from quantitative invasive 
measurements, and from NIRS facilitated an enhanced insight into the renal oxygenation and 
perfusion changes during aortic occlusion. Occlusion of the suprarenal aorta causes an abrupt 
interruption of blood flow into the kidney. At this early stage renal O2 consumption remains 
unaltered though. This induces a rapid and massive reduction in renal tissue pO2, which 
lowers blood pO2 and StO2 in the intrarenal (micro-)vasculature due to consumption of O2 in 
the face of ceased supply of O2. This deoxygenation of intrarenal Hb is made worse by a 
progressive rightward shift of the oxyHb dissociation curve during the occlusion due to 
intrarenal accumulation of CO2. With the onset of aortic occlusion, outflow of blood via the 
renal vein lowers the intrarenal blood volume. This is evident from the drop in the Hb per 
tissue volume recorded by NIRS (Grosenick et al., 2013) and manifests itself in the immediate 
decrease in kidney size detected with MRI (Pohlmann et al., 2014a). Assuming that the total 
volume of the tubular, interstitial, and cellular compartments does not change, the blood 
volume fraction becomes markedly reduced. Consequently, the reduction in blood volume 
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fraction compensates most of the T2* changes induced by increased deoxyHb blood 
concentration (Figure 5). Hence the decrease in T2* is much smaller than the actual change 
not only in tissue oxygenation but also in blood oxygenation.  
  Hypoxia/recovery yielded the strongest renal medullary tissue pO2/T2* correlation 
(Figure 3). The correlation was even closer than that observed for aortic occlusion/recovery 
(Pohlmann et al., 2014a). The pO2 decrease obtained during hypoxia (FiO2 8%) was not as 
fast as during aortic occlusion. Also, cortical pO2 decrease was less pronounced than the 
decline in pO2 obtained for aortic occlusion. Contrary to the pO2 response, the T2* decrease 
during hypoxia was much more pronounced than that during aortic occlusion. It stands to 
reason that aortic occlusion must reduce intrarenal blood oxygenation much more and more 
rapidly than hypoxia. Also, intrarenal pCO2 increases during occlusion due to CO2 
accumulation, but decreases during hypoxia due to hyperventilation induced by systemic 
hypoxemia (Marshall and Metcalfe, 1989). Decreased pCO2 shifts the oxyHb dissociation 
curve to the left so that at given pO2 the StO2 is increased. Opposite effects are induced by 
increased pCO2. Taking these considerations into account, the T2* decrease during aortic 
occlusion should be more pronounced compared with hypoxia. This expectation is not 
confirmed by the experimental findings. The response of T2* to hypoxia using a FiO2 of 8% 
overestimates the actual degree of blood (and tissue) hypoxia. The observed decrease in renal 
conductance during hypoxia indicates that renal vasoconstriction results in a reduction in 
intrarenal blood volume (Pohlmann et al., 2014a). Yet the vasoconstriction-related reduction 
in renal blood volume during hypoxia is most likely smaller versus the outflow-induced 
reduction in renal blood volume during aortic occlusion. Intriguingly, experimental findings 
derived from MR-PHYSIOL showed that the kidney size decreased more during hypoxia than 
during occlusion (Pohlmann et al., 2014a). This observation highlights an additional volume 
loss of renal tissue compartments other than the blood volume fraction during hypoxia. 
Contrary to aortic occlusion – where glomerular filtration ceases and along with it the 
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pressure gradient that drives tubular fluid toward the renal pelvis – filtration and tubular fluid 
flow will decrease but not cease during hypoxia. The outflow of tubular fluid causes a 
reduction in the tubular volume. Moreover, reabsorbed fluid cannot be drained by peritubular 
capillaries during occlusion because of the arrested blood flow. Consequently, the sum of the 
tubular plus the interstitial volumes remains unchanged. The situation is different during 
hypoxia where peritubular capillary blood flow is not arrested. In this case, reabsorbed fluid 
continues to be drained from the interstitium. Since the decrease in tubular volume is not 
counterbalanced by an increase in the interstitial volume, the sum of both volumes decreases. 
This translates into a larger decrease in the blood volume fraction during occlusion versus 
hypoxia, which might explain the discrepancies in the T2* and pO2 response to hypoxia and 
aortic occlusion.  
To generalize, differences in the T2* and pO2 responses to reversible maneuvers of 
hyperoxia, aortic occlusion and hypoxia lead to the conclusion that plain translation of 
quantitative results observed for one intervention of renal hemodynamics and oxygenation to 
another intervention is not appropriate. T2* may not accurately reflect blood oxygenation and 
may be confounded by vascular and tubular volume fraction under certain 
(patho)physiological conditions. 
 
Inter-layer heterogeneity of T2*/pO2 relation  
Arguably, the notion that pO2/T2* correlations obtained for specific renal regions can 
per se be extrapolated to other renal areas is somewhat premature (Pedersen et al., 2005). 
Major inter-layer differences in the T2*/pO2 correlations together with large differences in the 
linear regressions of T2*/pO2 in response to hyperoxia/recovery, occlusion/recovery, and 
hypoxia/recovery were reported from MR-PHYSIOL (Pohlmann et al., 2014a). For example, 
significant Spearman rank correlations between medullary T2* and tissue pO2 were observed 
for hypoxia/recovery (Figure 3), but – unlike the medulla – the cortex revealed the weakest 
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T2*/pO2 Spearman rank correlations and no significant linear correlation for the T2*/pO2 
response to hypoxia and recovery (Figure 6). To generalize, the stark inter-layer differences 
underline the need for due caution when extrapolating spatiotemporal T2*/pO2 changes 
obtained for specific renal regions to other renal areas.  
 
T2* response to iodixanol contrast medium 
Intra-renal hypoperfusion and hypoxia are key elements in the pathophysiology of x-
ray contrast-induced AKI. This hypothesis is based upon a number of animal studies that used 
invasive techniques to assess renal perfusion and oxygenation (Liss et al., 2009, Liss et al., 
1998, Seeliger et al., 2007, Heyman et al., 1991, Lancelot et al., 2002, Seeliger et al., 2014b, 
Seeliger et al., 2014a). Studies using BOLD-MRI confirmed that contrast medium (CM) 
administration affects renal oxygenation (Arakelyan et al., 2013, Li et al., 2014, Ji et al., 
2010). Intra-arterial administration of the high viscous CM (iodixanol) resulted in a transient 
increase in cortical T2* of up to 20%. Twenty minutes after CM administration the initial 
change in T2* was followed by a sustained decrease of about 10% below the pre-CM level 
(Figure 7) (Arakelyan et al., 2013). This T2* behaviour revealed striking differences when 
compared with invasively measured cortical tissue pO2 as illustrated in Figure 7. The initial 
overshoot in T2* observed for rats (Arakelyan et al., 2013) and pigs (Haneder et al., 2012) 
was not found for cortical tissue pO2 (Seeliger et al., 2007, Seeliger et al., 2014a). Moreover, 
whereas cortical T2* dropped only slightly below baseline (10%) cortical pO2 was found to be 
reduced by about 40% (Seeliger et al. 2014a). This mismatch between T2* and tissue pO2 
changes can be attributed, at least in part, to a decrease in the vascular volume fraction. 
Contrast medium-induced high tubular fluid viscosity results in an increase in the intra-
tubular pressure (Ueda et al., 1993, Seeliger et al., 2010). This pressure distends the tubules, 
which compresses intrarenal vessels due to the rather rigid renal capsule. The marked 
swelling of the kidney upon CM administration (Figure 7) most likely reflects the distension 
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of tubules. Data on the amount of Hb per cortical tissue volume obtained by NIRS corroborate 
the decrease in the vascular volume fraction (Figure 7). Another mechanism which contributes 
to the decrease in the vascular fraction is vasoconstriction (Seeliger et al., 2007) as indicated 
by the reduction in cortical vascular conductance (Figure 7). An additional effect that has a 
share in the disparities between T2* and tissue pO2 is the CM-induced leftward shift of the 
oxyHb dissociation curve (Kim et al., 1990). The impeded release of O2 from Hb decreases 
tissue pO2 but increases (venous) StO2, which induces an increase in T2*. 
To generalize, these results indicate that T2* underestimates CM-induced intra-renal 
hypoxia, mainly because of the decrease in the vascular volume fraction induced by an 
increase in tubular volume fraction and by vasoconstriction. 
 
Chronic kidney disease and renal T2*  
Renal tissue hypoperfusion and hypoxia are generally deemed an important 
mechanism in the progression from AKI to CKD. It may therefore appear surprising that a 
recent large scale patient study using T2* mapping at magnetic field strengths of 1.5 T and 3.0 
T reported no correlation between estimated GFR and medullary and cortical T2* for chronic 
kidney diseases (Michaely et al., 2012). Furthermore, medullary and cortical T2* were not 
related to gender and age (range 21-92 years) (Michaely et al., 2012). The authors concluded, 
that T2* mapping of a non-specific patient population is not able to discriminate between 
patients with different stages of CKD of various origins (Michaely et al., 2012). Irrespective 
of the heterogeneity of the patient cohort, the discrepancy between estimated GFR and renal 
T2* does not argue against intra-renal tissue hypoxia as a culprit in the development of CKD. 
With reduced GFR tubular reabsorption and renal O2 consumption also become reduced. 
Whether or not intra-renal oxygenation decreases depends primarily on the degree of 
reduction in renal perfusion and O2 delivery as compared to changes in GFR and O2 
consumption (Blantz and Deng, 2007). Unfortunately, renal perfusion was not assessed in the 
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study on CKD patients (Michaely et al., 2012). Recent MR-PHYSIOL findings provided a 
valuable contribution to the ongoing debate on the relationship between T2* and total renal 
blood flow (Pohlmann et al., 2014a). For the T2* to RBF relation significant Spearman 
correlations were deduced in response to hyperoxia/recovery, hypoxia/recovery and aortic 
occlusion/recovery. T2*/RBF correlations were even superior to those between T2* and tissue 
pO2. Keeping in mind that T2* provides a surrogate for blood oxygenation rather than tissue 
pO2 (Evans et al., 2007) there is a lucid explanation for this remarkable finding. Tissue pO2 
primarily reflects the balance between O2 supply and O2 demand. Because of O2 shunt 
diffusion, blood pO2 and StO2 in larger arterial and venous vessels exceed those in the 
capillaries as well as tissue pO2. The amount of O2 that is shunted depends not only on O2 
consumption but also on arterial O2 content and RBF (Blantz and Deng, 2007, Evans et al., 
2011a, Evans et al., 2013). To summarize, for a clinical assessment of renal oxygenation it is 
prudent to supplement BOLD MRI with MR based RBF measurements. 
 
Factors confounding renal T2* 
It is sensible to state that T2* is directly related to the amount of deoxyHb per tissue 
volume and hence correlated with tissue pO2 via blood pO2 and the oxyHb dissociation curve. 
The recent findings on the correlation between T2* and tissue pO2 revealed discrepancies that 
point at factors other than the known shifts of the oxyHb dissociation curve and changes in 
haematocrit, which may also confound the renal T2*/tissue pO2 relationship. The T2* to tissue 
pO2 correlation differences between interventions of hyperoxia, hypoxia and aortic occlusion 
together with the renal vascular conductance and kidney size data obtained by MR-PHYSIOL 
indicate that changes in the blood volume fraction considerably influence renal T2*. Changes 
in renal vascular conductance point at changes in intrarenal blood volume. This occurs via 
passive circular distension of vessels following changes in the transmural pressure gradient, or 
by active vasomotion.  
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Alterations in kidney size may be induced by volume changes in any of the renal fluid 
compartments. Besides the vasculature, the interstitial and the tubular compartments could 
also experience rapid volume changes and could therefore modulate the blood volume 
fraction. The tubular volume fraction is a unique feature of the kidney; it is quite large and 
can rapidly change due to (i) changes in filtration, (ii) alterations in tubular outflow towards 
the pelvis, (iii) modulation of the transmural pressure gradient, and (iv) changes in resorption.  
Detailing the impact of changes in renal hemodynamics, tissue oxygenation, vascular 
and tubular volume fractions on T2* under various (patho)physiological conditions certainly 
requires a more sophisticated approach including insights from modeling the T2* signal in 
voxels using multi-compartment models or Monte-Carlo simulations (Zhang et al., 2014). En 
route towards a comprehensive model Figure 8 provides a schematic survey on the potential 
contributions of several confounders to T2*. These include changes in (i) the tubular 
compartment, (ii) the intrarenal vascular compartment, and (iii) Hb concentration per blood 
volume (haematocrit). Aortic occlusion (or that of the renal artery) results only in moderate 
reduction of renal T2* as illustrated in the empirical model shown in Figure 8. Figure 8 also 
illustrates a massive T2* reduction following occlusion of the renal vein. Simultaneous 
occlusion of the renal vein and artery causes an intermediate T2* reduction as pointed out in 
Figure 8. In each of these three cases, tissue pO2, blood pO2, and StO2 approach zero. Yet the 
vascular volume fraction is reduced in case of arterial occlusion, increased in case of venous 
occlusion, and unchanged in case of the common arterio-venous occlusion. As also illustrated 
in Figure 8, vasodilation causes a T2* decrease due to an increase in the vascular volume 
fraction, although renal tissue pO2, blood pO2, and StO2 increase due to improved O2 delivery. 
Vasoconstriction induces an increase in T2* despite reduced O2 delivery due to reduction in 
vascular volume fraction. Distension of tubules (e.g. induced by x-ray contrast media) results 
in increase in T2* in the face of primarily unchanged StO2, blood and tissue pO2 due to 
reduced vascular volume fraction (Figure 8). Anaemia or an increase in plasma skimming 
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evoke an increase in T2* despite the drop in O2 delivery and tissue pO2 (Figure 8). Finally, 
changes in the inspiratory O2 fraction change renal T2*. Hypoxia decreases T2* in parallel 
with StO2, blood and tissue pO2. The effect of hyperoxia on T2* is small. 
 
Future directions for pushing the limits of renal MRI 
The recognition that renal T2* does not quantitatively mirror renal tissue oxygenation 
in several (patho)physiological conditions and that T2* may not reflect blood oxygenation 
quantitatively in some scenarios should induce due caution for quantitative interpretation of 
BOLD-MRI. This recognition must not discourage clinical and basic scientists to make good 
use of the capabilities of BOLD-MRI. On the contrary, it should attract talent and resources 
for refining and perfecting the potential of the next generation of renal MRI methodology 
with the goal to further quantitative interpretation of BOLD-MRI. Explorations into the renal 
response to a specific (patho)physiologic scenario or pharmacologic paradigm should include 
quantitative data on the T2*/tissue pO2 relation using experimental approaches similar to MR-
PHYSIOL. The information deduced from such a multi-modality approach is instrumental if 
not essential to interpret changes in renal oxygenation and perfusion, based upon changes in 
T2* alongside changes in physiological parameters. Admittedly, this approach is only feasible 
in animal models. Notwithstanding this limitation, this review aims at encouraging pioneers 
and early adopters interested in pursuing renal BOLD MRI in clinical settings including 
patients with AKI or CKD. Yet, it sets a gentle reminder that it is prudent to supplement 
BOLD-MRI with MR-based assessment of renal perfusion. 
Deciphering the relation between regional renal T2* and tissue pO2 – including the role 
of the T2* confounders vascular volume fraction, tubular volume fraction and oxyHb 
dissociation curve – requires further research. To be rendered a quantitative physiological 
approach, BOLD-MRI needs to be calibrated with established quantitative physiological 
measurements (marked in light blue in Figure 9). With this in mind Figure 9 attempts to 
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provide a basic scheme of an integrative approach that makes good use of the capabilities of 
magnetic resonance, physiological measurements and near infrared spectroscopy. Productive 
engagement in this area carries on to drive further developments including validation and 
calibration of MR with the ultimate goal to provide quantitative means for interpretation of 
renal hemodynamics, renal oxygenation, renal blood volume fraction and tubular volume 
fraction related parametric MRI (Figure 9). This requires that renal blood oxygenation level 
associated T2* changes need to be differentiated from T2* changes induced by changes in the 
T2* confounders tubular and vasculature volume fraction (marked in red in Figure 9). To meet 
this goal the renal MRI portfolio needs to entail T2* mapping to probe for changes in blood 
oxygenation level but also T2 mapping and proton density imaging to monitor net water 
changes and fluid shifts (marked in dark blue in Figure 9). T2 mapping would also help to 
discriminate the susceptibility induced contributions (T2') from the T2 relaxation contributions 
to T2*. For this purpose it is also appealing to pursue quantitative susceptibility mapping 
(QSM). QSM provides a novel MR contrast mechanism to determine apparent magnetic 
susceptibility in tissue, which is useful for identification of BOLD contributions. Arguably, 
the potential of renal QSM is as yet untapped, with an early application being intriguing but 
limited to ex vivo investigations (Xie et al., 2014).  
For a comprehensive characterization of renal oxygenation and perfusion it is prudent 
to include MR assessment of renal blood volume (RBV) using intravascular contrast agents 
such as ultrasmall superparamagnetic iron oxide (USPIO) based agents (Wang et al., 2013, 
Storey et al., 2011) to probe for vasodilation, vasoconstriction and other changes in the blood 
volume fraction as illustrated in Figure 9. For this purpose it is essential to first study the renal 
oxygenation and perfusion response to the intravascular administration of USPIOs using 
established physiological in vivo measurements in order to offset, for instance, concerns 
regarding USPIO application in patients with potentially compromised kidney function. 
Admittedly, the use of USPIOs for RBV assessment runs the caveat that the USPIO induced 
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T2* changes might interfere with T2* changes caused by the BOLD effect. For example, it is 
fair to assume that following administration of USPIO the balance of the two competing T2* 
effects during aortic occlusions (changes in deoxyHb vs. decrease in RBV) is shifted in favour 
of the sensitivity to RBV changes due to the strong T2* effect of iron oxides (Pohlmann et al., 
2014b). The tubular volume fraction can be scrutinized with apparent water diffusion 
coefficient (ADC) determination or intra-voxel incoherent motion techniques (Hueper et al., 
2013, Eckerbom et al., 2013, Zhang et al., 2012a, Ichikawa et al., 2013, Niendorf et al., 1996) 
(Figure 9). Arterial spin labeling MR techniques provide means for MR based assessment of 
renal perfusion (Wang et al., 2012, Zhang et al., 2012a) and can be used for examination of 
regional renal blood flow (Liu et al., 2012).  
The need for solving the renal oxygenation and perfusion conundrum can be expected to 
continue to spur and drive technological MR developments. Fluorine MRI (19F MR) is an 
innovative technology which provides an alternative for probing renal blood volume and for 
assessing renal tissue pO2 or renal blood pO2 (Figure 9) as demonstrated in recent feasibility 
studies (Liu et al., 2011, Hu et al., 2013). For this purpose 19F perfluorocarbon nanoparticles 
can be measured directly in vivo in rather sparse concentrations (Hu et al., 2013). The specific 
advantages emerging from the use of 19F MR are twofold: a virtual absence of 19F in the body 
tissues yielding background free images with complete signal selectivity and a possibility to 
quantify the 19F MR signal with spectroscopy. Arguably, it is too early to make ultimate 
statements since renal 
19
F MR is still in its infancy and the potential of renal 
19
F MR is as yet 
untapped. Yet recent preliminary reports on the capabilities of 
19
F MR of the kidney and 
radiofrequency coil developments for 
19
F MR are heartening (Waiczies et al., 2013, Pohlmann 
et al., 2014c). 
23Na MRI is another emerging heteronuclear MR tool to examine renal sodium 
content in small rodents and in humans (Haneder et al., 2014, Kalayciyan et al., 2013, Kopp et 
al., 2012).  
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The gain in intrinsic sensitivity and the linear relationship between magnetic field 
strength and microscopic susceptibility (Turner et al., 1993, van der Zwaag et al., 2009, 
Donahue et al., 2011, Meloni et al., 2013) renders it conceptually appealing to pursue renal 
MRI at ultrahigh magnetic field strengths (Niendorf et al., 2013, Niendorf et al., 2010). For all 
these reasons MR methodology established for human MRI needs to be carefully adapted to 
free breathing rodents and vice versa. These efforts should be designed to foster enhanced 
spatio-temporal resolution using state-of-the art parallel imaging (Niendorf and Sodickson, 
2008, Niendorf and Sodickson, 2006b, Niendorf et al., 2005, Niendorf and Sodickson, 2006a), 
advanced MR pulse sequences (Klix et al., 2014), explorations into simultaneous T2*/T2 
sensitized MRI to reduce scan times (Fuchs et al., 2013), application of T2* mapping 
techniques free of image distortion (Niendorf, 1999, Heinrichs et al., 2009) and development 
of novel radiofrequency antennas to enhance the sensitivity of MR detectors (Dieringer et al., 
2011, Thalhammer et al., 2012, Winter et al., 2012, Wagenhaus et al., 2012, Grassl et al., 
2013, Graessl et al., 2014a, Graessl et al., 2014b).  
On the invasive side, the probes incorporated in MR-PHYSIOL for total renal blood 
flow, local tissue perfusion and tissue pO2 measurements could be complemented by 
intermittent blood samples to measure parameters such as haematocrit, pO2, Hb concentration, 
and StO2. This should shed further light into, e.g., the role of shifts in the oxyHb dissociation 
curve (Figure 9). A recent report also highlighted a novel approach that relies on implantation 
of fluorescence optodes in the femoral artery and renal vein to elucidate renal O2 delivery and 
consumption (Abdelkader et al., 2014). 
The development and application of multi-modality approaches continues to be in a 
state of creative flux. It is to be expected that future hybrid implementations may include 
optical imaging techniques such as NIRS. Notwithstanding its depth penetration constraints 
which at present limits its application to the renal cortex, NIRS has the potential to help 
characterize renal oxygenation. NIRS was applied to monitor changes of StO2 and Hb 
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concentration per tissue volume in the kidney of rats after administration of contrast agents 
(Krause et al., 2002). With advanced NIRS approaches it is even possible to measure absolute 
values of Hb concentration and StO2 which was demonstrated for the renal cortex of small 
animals (Grosenick et al., 2013). Other efforts push into the direction of characterizing renal 
perfusion by employing near infrared laser speckle imaging (Bezemer et al., 2010) or by 
detecting NADH autofluorescence (Raman et al., 2009).  
To conclude, further explorations are essential before the quantitative capabilities of 
parametric MRI can be translated from experimental research to the clinic to improve our 
understanding of hemodynamics/oxygenation in kidney disorders. Moving T2* sensitized 
MRI from the research area into the clinic remains challenging but has spurred the drive 
towards a comprehensive stand-alone MR protocol for assessment of renal haemodynamics 
and oxygenation. As parametric mapping of T2* and other MR biomarkers become 
increasingly used in preclinical research and clinical science, they should help to further 
advance the potentials of MR for assessing kidney diseases. 
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Figure Captions 
 
Figure 1:  
Coronal views of rat kidneys: a) T2* sensitized MR image acquired ex vivo using an in-plane 
spatial resolution spatial resolution 50 m (cortex COR; outer medulla OM; inner medulla 
IM), b) photograph of a freshly excised rat kidney, c) T1-weighted anatomical MR image 
acquired ex vivo using an in-plane spatial resolution of 50 m, d) high spatial resolution x-ray 
image acquired ex vivo , e+f) modestly and heavily T2* weighted in vivo MR images acquired 
with an in-plane spatial resolution of 220 m. The 1 cm scale bar illustrates the size of the rat 
kidney. 
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Figure 2:  
Examples of T2* mapping based monitoring of left) ischemia and reperfusion, center) 3 min 
and 90 min after the injection of the contrast medium Iodixanol, and right) during brief 
periods of hypoxia and hyperoxia in rats. Shown are T2* difference maps of the kidney 
(colour-coded) between each intervention and the baseline image before the respective 
intervention. 
 
 
 
 
 
 
 
 
 
 
 
page 39 
 
Figure 3:  
Parametric correlation analysis (Pearson’s analysis) and non-parametric correlation analysis 
(Spearman’s analysis) between relative changes of outer medullary T2* and relative changes 
of medullary tissue pO2 in response to a hypoxia & recovery maneuver. The coefficient of 
determination for Pearson (Rp
2
) and the linear regression equation, and the Spearman 
coefficient (Rs
2
) are given. Hypoxia & recovery revealed a strong medullary tissue pO2/T2* 
correlation. These findings indicate that relative changes in T2* qualitatively reflect changes 
in medullary tissue pO2 induced by hypoxia.  
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Figure 4: 
Coronal views of a rat kidney acquired in vivo under physiological conditions baseline: a) T2* 
weighted MR image using an in-plane spatial resolution of 220 m. The scale bar illustrates 
the size of the rate kidney. b) color coded renal T2*-map derived from a series of images 
acquired with different T2* weighting and an in-plane spatial resolution of 220 m, c) T2 
weighted renal MR image (in-plane spatial resolution of 220 m) and d) color coded map of 
the renal apparent diffusion coefficient (ADC) derived from a series of images acquired with 
different diffusion weighting and an in-plane spatial resolution of 220 m. Absolute values of 
baseline renal T2* are higher in the inner medulla versus the outer medulla and cortex. T2 in 
the inner medulla is higher than in the outer medulla and cortex, which indicates higher inner 
medullary water content, as confirmed by the higher ADC.  
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Figure 5: 
Synopsis of changes in renal parameters which were observed in response to aortic occlusion. 
Changes in renal parameters were derived from MR-PHYSIOL including cortical T2*, kidney 
size, and cortical tissue pO2 and from near infrared spectroscopy (NIRS) using time-domain 
NIRS setup equipped with three picosecond diode lasers (wavelength of 690 nm, 800 nm and 
830 nm) and a multi-distance fiber probe which was positioned directly above the exposed rat 
kidney to determine cortical O2 saturation of Hb and the cortical concentration of Hb per 
tissue volume. Aortic occlusion caused a rather modest cortical T2* decrease of 11%. MRI 
revealed a 4% reduction in kidney size during aortic occlusion. Cortical tissue pO2 revealed 
an 88% reduction. Oxygen saturation of Hb derived from NIRS decreased by approximately 
40%. Furthermore, NIRS detected a 30% decrease in the Hb concentration per cortical tissue 
volume upon aortic occlusion.  
 
 
page 42 
 
 
Figure 6: 
Parametric correlation analysis (Pearson’s analysis) and non-parametric correlation analysis 
(Spearman’s analysis) between relative changes of cortical T2* and relative changes of 
cortical tissue pO2 in response to a hypoxia & recovery maneuver. The coefficient of 
determination for Pearson (Rp
2
) and for Spearman (Rs
2
) is given. Unlike the medulla (see 
Figure 3) the cortex revealed very weak T2*/pO2 Spearman rank correlations and no 
significant linear correlation for the T2*/pO2 response to hypoxia & recovery.  
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Figure 7: 
Effects of administration of the x-ray contrast medium (CM), iodixanol 320 mg iodine/ml (1.5 
ml bolus injection into the thoracic aorta) in rats. Top: T2* maps acquired before and 3, 10, 
20, 30 and 50 min after CM administration. For comparison, a T2* map obtained during 
hypoxia (FiO2 8%) is shown on the far right. Bottom: Time course of renal parameters 
(mean±SEM from cohorts of 10 to 13 animals) derived from parametric MRI (cortical T2*, 
kidney size), invasive physiological measurements (cortical tissue pO2, cortical vascular 
conductance) and from near-infrared spectroscopy (cortical Hb per tissue volume, cortical O2 
saturation of Hb). Within the first 10 min following CM administration a transient T2* 
increase of about 20% was observed in the cortex. During the same period CM resulted in 
marked swelling of the kidneys with a maximum increase of 7%. The transient increase in T2* 
was followed by a small decrease to about -10% of baseline. Cortical tissue pO2 presented a 
decrease of about 40%. The amount of Hb per tissue decreased rapidly to about 75% of 
baseline within 60-90 s of CM administration, thereafter slowly regained baseline level. 
Cortical O2 saturation of Hb showed a transient dip within the initial 90 s and started to slowly 
decrease after about 20 min.  
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Figure 8: 
Schematic overview of the key factors that govern renal T2*. This includes T2* alterations due 
to changes in the tubular compartment (represented by changes in their radius, r), the 
intrarenal vascular compartment (represented by changes in their radius, r), renal tissue pO2 
(tpO2), blood pO2 (bpO2), haematocrit (Hct) and O2 saturation of Hb (StO2). The scheme 
depicts primary effects of the respective intervention/alteration only, not effects that represent 
the kidneys response to these changes. The amount of deoxygenated haemoglobin per tissue 
volume element (voxel) that is related to T2* is represented by the quantity of blue 
erythrocytes, the O2 saturation of Hb is represented by the ratio of red-to-blue erythrocytes. 
Tissue pO2 values are related to changes in O2 delivery (due to changes in either haematocrit 
or StO2) under the assumption that O2 consumption is unchanged. Please note that the 
numbers given for T2* are not milliseconds but arbitrarily chosen numbers with baseline T2* 
set to 1.0.  
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Figure 9:  
Overview of an experimental concept customized to unravel the link between renal T2* and 
tissue pO2. This concept includes the role of the T2* confounding parameters vascular and 
tubular volume fraction, oxyHb dissociation curve and Hb concentration per blood volume 
(haematocrit), all marked in red. For a stand-alone MR protocol blood volume fraction, 
tubular volume fraction and oxyHb dissociation curve T2* contributions must be 
differentiated from renal BOLD T2* using standardized test procedures alongside with 
calibration with physiological measurements, all marked in light blue. These calibration 
efforts include a multi-modality approach that affords simultaneous acquisition of various MR 
parameters, invasively measured established physiological parameters, and parameters 
obtained by optical imaging techniques. To meet this goal an renal MR oximetry protocol is 
proposed which comprises blood oxygenation level dependent T2* and T2 mapping, 
assessment of renal blood flow with arterial spin labeling MR, probing tubular water with 
diffusion weighted MRI, MR based kidney size measurements, detailing blood pO2 with 
19
F 
fluorine MRI and monitoring of renal blood volume with intravascular contrast agent 
enhanced MR. Renal oximetry needs to be calibrated by quantitative physiological 
measurements because of its qualitative nature. For detailed description and explanations see 
text.  
 
